Cypress Capital LLC Makes New Investment in Oracle Corporation $ORCL

Cypress Capital LLC bought a new position in Oracle Corporation (NYSE:ORCL) in the 2nd quarter, according to its most recent disclosure with the SEC. The firm bought 1,276 shares of the enterprise software provider’s stock, valued at approximately $279,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC lifted its stake in shares of Oracle by 189.3% in the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after purchasing an additional 100,494 shares during the period. Revolve Wealth Partners LLC raised its holdings in Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after purchasing an additional 404 shares in the last quarter. New York State Common Retirement Fund raised its holdings in Oracle by 1.7% in the first quarter. New York State Common Retirement Fund now owns 2,056,038 shares of the enterprise software provider’s stock worth $287,455,000 after purchasing an additional 34,233 shares in the last quarter. Fulton Breakefield Broenniman LLC lifted its position in Oracle by 20.9% during the first quarter. Fulton Breakefield Broenniman LLC now owns 2,840 shares of the enterprise software provider’s stock valued at $397,000 after buying an additional 490 shares during the period. Finally, Louisiana State Employees Retirement System boosted its holdings in shares of Oracle by 0.9% during the 1st quarter. Louisiana State Employees Retirement System now owns 87,200 shares of the enterprise software provider’s stock valued at $12,191,000 after buying an additional 800 shares in the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Insiders Place Their Bets

In other Oracle news, Director Naomi O. Seligman sold 2,222 shares of the business’s stock in a transaction on Friday, September 26th. The shares were sold at an average price of $288.91, for a total transaction of $641,958.02. Following the completion of the sale, the director directly owned 29,225 shares in the company, valued at approximately $8,443,394.75. The trade was a 7.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Stuart Levey sold 19,758 shares of the firm’s stock in a transaction on Friday, October 10th. The stock was sold at an average price of $300.00, for a total value of $5,927,400.00. Following the completion of the transaction, the executive vice president owned 18,429 shares in the company, valued at approximately $5,528,700. This trade represents a 51.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 204,254 shares of company stock worth $60,227,807 in the last 90 days. Insiders own 40.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ORCL. Stifel Nicolaus increased their price target on shares of Oracle from $250.00 to $350.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Morgan Stanley upped their price objective on shares of Oracle from $246.00 to $320.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 23rd. BMO Capital Markets set a $355.00 target price on shares of Oracle and gave the company an “outperform” rating in a research note on Monday, October 13th. BNP Paribas set a $377.00 price target on Oracle in a research report on Wednesday, September 10th. Finally, Rothschild Redb raised Oracle to a “strong sell” rating in a research report on Thursday, September 25th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $323.69.

Oracle Trading Down 1.9%

Shares of NYSE:ORCL opened at $239.15 on Monday. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. Oracle Corporation has a 1 year low of $118.86 and a 1 year high of $345.72. The company has a market cap of $681.77 billion, a P/E ratio of 55.36, a PEG ratio of 2.96 and a beta of 1.51. The stock’s fifty day moving average price is $279.32 and its 200-day moving average price is $231.30.

Oracle (NYSE:ORCL) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.Oracle’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the firm posted $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Sell-side analysts expect that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, October 23rd. Investors of record on Thursday, October 9th were issued a $0.50 dividend. The ex-dividend date was Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.8%. Oracle’s dividend payout ratio (DPR) is currently 46.30%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.